---
title: "MOSKOWITZ PAUL I — Ownership Dossier"
canonical: https://whiteintel.dev/entity/887bb126-e7cb-5448-8f0e-6fb9f290731b
json: https://whiteintel.dev/api/public/dossier/887bb126-e7cb-5448-8f0e-6fb9f290731b
identifier: sec:0001645594
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MOSKOWITZ PAUL I

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001645594`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/887bb126-e7cb-5448-8f0e-6fb9f290731b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/887bb126-e7cb-5448-8f0e-6fb9f290731b  

## Ownership & control

### Holdings / subsidiaries

- **Sonnet BioTherapeutics Holdings, Inc.** (director) — https://whiteintel.dev/entity/f1856aba-55ba-5308-8c33-e1abaab7f3fc

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MOSKOWITZ PAUL I**. Human view: https://whiteintel.dev/entity/887bb126-e7cb-5448-8f0e-6fb9f290731b · Structured JSON: https://whiteintel.dev/api/public/dossier/887bb126-e7cb-5448-8f0e-6fb9f290731b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._